Lloyd Johnston
Nessuna posizione attualmente
Profilo
Lloyd Johnston worked as Vice President-Operations at Alkermes, Inc. from 2004 to 2008.
He then worked as COO and Senior Vice President-Research & Development at Selecta Biosciences, Inc. from 2014 to 2023.
Prior to that, he was a Member at Advanced Inhalation Research, Inc. from 1998 to 1999.
Johnston received his undergraduate degree from Queen's University and his graduate and doctorate degrees from Massachusetts Institute of Technology.
Precedenti posizioni note di Lloyd Johnston
| Società | Posizione | Fine |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Chief Operating Officer | 13/11/2023 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Chief Operating Officer | 01/01/2008 |
Advanced Inhalation Research, Inc.
 Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a private company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Corporate Officer/Principal | 01/01/1999 |
Formazione di Lloyd Johnston
| Queen's University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Advanced Inhalation Research, Inc.
Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a private company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Health Technology |
- Borsa valori
- Insiders
- Lloyd Johnston
